A case report of long course of rituximab in treatment of refractory membranous nephropathy
10.3760/cma.j.cn121361-20191226-00010
- VernacularTitle:尝试长疗程利妥昔单抗治疗难治性原发性膜性肾病一例
- Author:
Yumei LI
1
;
Yue WANG
;
Song WANG
;
Danxia ZHENG
Author Information
1. 北京大学第三医院肾内科 100000
- From:
Clinical Medicine of China
2020;36(6):561-563
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, more and more reports have been reported on the treatment of refractory primary membranous nephropathy with rituximab in bed, and its effect has been confirmed.A case of refractory primary membranous nephropathy was treated in the Department of Nephrology, Peking university Third Hospital.After the treatment of hormone combined with cyclophosphamide, cyclosporine and tacrolimus was ineffective, the patients were treated with low-dose rituximab for 2 years according to their condition, and the condition of the patients was finally relieved.
